Combined anti-hepatocellular carcinoma therapy inhibit drug-resistance and metastasis via targeting “substance P-hepatic stellate cells-hepatocellular carcinoma” axis

Autor: Li, Zhipeng a, 1, Wang, Fangqing a, 1, Li, Yanying a, 1, Wang, Xiaoxue a, Lu, Qiao a, Wang, Di b, Qi, Cuiping b, Li, Chenglei c, Li, Zhaohuan c, Lian, Bo a, Tian, Guixiang a, Gao, Zhiqin a, ∗∗, Zhang, Bo c, ∗∗∗, Wu, Jingliang a, ∗
Zdroj: In Biomaterials September 2021 276
Databáze: ScienceDirect